Neurol. praxi. 2022;23(6):442-446

Psychiatric disorders in patients with amyotrophic lateral sclerosis

MUDr. Jana Milerová, Ph.D.
Neurologická klinika 1. lékařská fakulta, Univerzita Karlova a Všeobecná fakultní nemocnice v Praze

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease leading to muscle weakness and death within 2-5 years. In the absence of a causal treatment, care focuses on reducing the concomitant complications of ALS. Psychiatric issues in ALS patients are common and neglected in clinical practice. The disorders described here - behavioral and cognitive symptoms of frontotemporal degeneration, pseudobulbar affect, and depressive and anxiety disorders - negatively modify the course of the underlying disease, shorten survival time, significantly exacerbate the suffering of ALS patients, and substantially reduce the quality of life and therefore deserves more attention in clinical practice.

Keywords: amyotrophic lateral sclerosis, cognitive deficit, behavioral changes, pseudobulbar affect, depressive disorder, quality of life.

Received: October 23, 2022; Revised: October 23, 2022; Accepted: October 25, 2022; Prepublished online: October 25, 2022; Published: December 2, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Milerová J. Psychiatric disorders in patients with amyotrophic lateral sclerosis. Neurol. praxi. 2022;23(6):442-446.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abrahams S, Goldstein LH, Al­‑Chalabi A, et al. Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1997;62(5):464-472. doi: 10.1136/JNNP.62. 5. 464. Go to original source...
    2. Averill AJ, Kasarskis EJ, Segerstrom SC. Psychological health in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8(4):243-54.doi: 10.1080/17482960701374643. Go to original source... Go to PubMed...
    3. Beldman E, Raaphorst J, Klein M, et al. The cognitive profile of behavioural variant FTD and its similarities with ALS: a systematic review and meta­‑analysis. J Neurol Neurosurg Psychiatry. 2018; 89(9):995-1002. doi:10.1136/jnnp-2017-317459. Go to original source... Go to PubMed...
    4. Bezdíček O, Marková L, Soósová N, et al. Pilotní studie Edinburské kognitivně­‑behaviorální zkoušky pro amyotrofickou laterální sklerózu na české populaci. Cesk Slov Neurol N. 2018;81(2):208-212. doi:10.14735/amcsnn2018208. Go to original source...
    5. Cummings JL, Arciniegas DB, Brooks BR, et al. Defining and diagnosing involuntary emotional expression disorder. CNS Spectr. 2006;11(S6):1-7. doi:10.1017/s1092852900026614. Go to original source... Go to PubMed...
    6. De Carvalho M, Matias T, Coelho F, et al. Motor neuron disease presenting with respiratory failure. J Neurol Sci. 1996;139:117-122. Go to original source... Go to PubMed...
    7. De Marchi F, Sarnelli MF, Solara V, et al. Depression and risk of cognitive dysfunctions in amyotrophic lateral sclerosis. Acta Neurol Scand. 2019;139(5):438-445. doi: 10.1111/ane.13073. Go to original source... Go to PubMed...
    8. Floeter MK, Katipally R, KimMP, et al. Impaired corticopontocerebellar tracts underline pseudobulbar affect in motor neuron disorders. Neurology. 2014;83(7):620-627. doi: 10.1212. Go to original source... Go to PubMed...
    9. Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implication of assessment. Lancet Neurol. 2013;12(4):368-80. doi 10.1016/S1474-4422(13)70026-7. Go to original source... Go to PubMed...
    10. Hanna J, Feinstein A, Morrow SA. The association of pathological laughing and crying and cognitive impairment in multiple sclerosis. J Neurol Sci. 2016;15;361:200-3. doi: 10.1016/j.jns.2016. 01. 002. Go to original source...
    11. Höschl C, Libiger J, Švestka J. Psychiatrie. Praha: Tigis. 2002; 895 s. ISBN 80-9001301-5.
    12. Kamminga J, Leslie FV, Hsieh S, et al. Syntactic comprehension deficits across the FTD­‑ALS continuum. Neurobiol Aging. 2016;41:11-18. doi: 10.1016/j.neurobiolaging.201602.002. Go to original source...
    13. Khishchenko N, Allen KD, Coffman CJ, et al. Time to diagnosis in the National Registry of Veterans with Amyotrophic Lateral Sclerosis. Amyotroph Lateral Scler. 2010;11(1-2):125-32. doi: 10.3109/17482960802572681. Go to original source... Go to PubMed...
    14. Lochhead JD, Maguire GA, Nelson MA. Pseudobulbar Affect Versus Depression: Issues in Diagnosis and Treatment. Psychiatric Times. 2018; 35(7).
    15. Maessen M, Veldink JH, Onwuteaka­‑Philipsen BD, et al. Euthanasia and physician­‑assisted suicide in amyotrophic lateral sclerosis: a prospective study. J Neurol. 2014;261(10):1894-901. doi: 10.1007/s00415-014-7424-6. Go to original source... Go to PubMed...
    16. Miller A, Pratt H, Schiffer RB. Pseudobulbar affect: the spectrum of clinical presentation, etiologies and treatments. Expert Rev Neurother. 2011; 11(7):1077-1088. doi10.1586/ern.11. 68. Go to original source... Go to PubMed...
    17. Olney NT, Goodkind MS, Lomen­‑Hoerth C, et al. Behaviour, physiology and experience of pathological laughing and crying in amyotrophic lateral sclerosis. Brain. 2011;134(Pt 12):3458-69. doi: 10.1093/brain/awr297. Go to original source... Go to PubMed...
    18. Pinto­‑Grau M, Donohoe B, O'Connor S, et al. Patterns of Language Impairment in Early Amyotrophic Lateral Sclerosis. Neurol Clin Pract. 2021;11(5):e634-e644. doi: 10.1212/CPJ.0000000000001006. Go to original source... Go to PubMed...
    19. Poeck K. Pathologishes Lachen und Weinen bei bulbärer myatrophischer Lateralsklerose. Dtsch Med Wochenschr. 1969; 94(7):310-314. doi:10.1055/s-0028-1108948. Go to original source... Go to PubMed...
    20. Rabkin JG, Albert SM, Del Bene ML et al. Prevalence of depressive disorders and change over time in late­‑stage ALS. Neurology. 2005;12;65(1):62-7. doi:10.1212/01. Go to original source...
    21. Roos E, Mariosa D, Ingre C, et al. Depression in amyotrophic lateral sclerosis. Neurology. 2016;14;86(24):2271-7. doi: 10.1212/WNL.0000000000002671. Go to original source... Go to PubMed...
    22. Rusina R, Matěj R, Cséfalvay Z, et al. Frontotemporální demence. Cesk Slov Neurol N. 2021; 84/117(1):9-29. doi: 10.48095/cccsnn20219. Go to original source...
    23. Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis- frontotemporal spectrum disorder (ALS­‑FTDS): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(3-4):153-174. doi: 10.1080/21678421.2016.1267768. Go to original source... Go to PubMed...
    24. Thakore NJ, Pioro EP. Laughter, crying and sadness in ALS. J Neurol Neurosurg Psychiatry. 2017;88(10):825-831. doi: 10.1136/jnnp-2017-315622. Go to original source... Go to PubMed...
    25. Tsai RM, Boxer AL. Therapy and clinical trials in frontotemporal dementia: past, presen, and future. J Neurochem. 2016;138(Suppl 1):211-221. doi:10.1111/jnc.13640. Go to original source... Go to PubMed...
    26. Uhrová T, Roth J. Neuropsychiatrie. Praha: Maxdorf. 2020; s. 965 s. ISBN 978-80-7345-619-1.
    27. van ES MA, Hardiman O, Chio A, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084-98. Go to original source... Go to PubMed...
    28. Young FG, Nguyen D. Treatment of pseudobulbar affect (PBA) in a patient with a history of traumatic brain injury, partial brain resection, and brainstem stroke: a case report. J Med Case Rep. 2020;14(1):235. doi: 10.1186/s13256-020-02525-3. Go to original source... Go to PubMed...
    29. Yunusova Y, Ansari J, Ramirez J, et al. Frontal anatomical correlates of cognitive and speech motor deficits in amyotrophic lateral sclerosis. Behav Neurol. 2019;2019:9518309. doi: 10.1155/2019/9518309. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.